1. Home
  2. SEPN vs DSU Comparison

SEPN vs DSU Comparison

Compare SEPN & DSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • DSU
  • Stock Information
  • Founded
  • SEPN 2022
  • DSU 1998
  • Country
  • SEPN United States
  • DSU United States
  • Employees
  • SEPN N/A
  • DSU N/A
  • Industry
  • SEPN
  • DSU Finance Companies
  • Sector
  • SEPN
  • DSU Finance
  • Exchange
  • SEPN NYSE
  • DSU Nasdaq
  • Market Cap
  • SEPN 631.0M
  • DSU 504.9M
  • IPO Year
  • SEPN 2024
  • DSU N/A
  • Fundamental
  • Price
  • SEPN $5.70
  • DSU $10.49
  • Analyst Decision
  • SEPN Buy
  • DSU
  • Analyst Count
  • SEPN 4
  • DSU 0
  • Target Price
  • SEPN $33.00
  • DSU N/A
  • AVG Volume (30 Days)
  • SEPN 420.0K
  • DSU 148.2K
  • Earning Date
  • SEPN 03-27-2025
  • DSU 01-01-0001
  • Dividend Yield
  • SEPN N/A
  • DSU 10.06%
  • EPS Growth
  • SEPN N/A
  • DSU N/A
  • EPS
  • SEPN N/A
  • DSU N/A
  • Revenue
  • SEPN $1,075,000.00
  • DSU N/A
  • Revenue This Year
  • SEPN N/A
  • DSU N/A
  • Revenue Next Year
  • SEPN N/A
  • DSU N/A
  • P/E Ratio
  • SEPN N/A
  • DSU N/A
  • Revenue Growth
  • SEPN 611.92
  • DSU N/A
  • 52 Week Low
  • SEPN $4.17
  • DSU $9.22
  • 52 Week High
  • SEPN $28.99
  • DSU $11.40
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • DSU 39.76
  • Support Level
  • SEPN N/A
  • DSU $10.48
  • Resistance Level
  • SEPN N/A
  • DSU $10.52
  • Average True Range (ATR)
  • SEPN 0.00
  • DSU 0.07
  • MACD
  • SEPN 0.00
  • DSU 0.01
  • Stochastic Oscillator
  • SEPN 0.00
  • DSU 34.50

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About DSU Blackrock Debt Strategies Fund Inc.

Blackrock Debt Strategies Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide current income by investing in a diversified portfolio of U.S. companies' debt instruments including corporate loans. The fund's secondary investment objective is to provide capital appreciation.

Share on Social Networks: